Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Statistics

Total Valuation

COGT has a market cap or net worth of $2.11 billion. The enterprise value is $1.94 billion.

Market Cap	2.11B
Enterprise Value	1.94B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

COGT has 139.78 million shares outstanding. The number of shares has increased by 22.67% in one year.

Current Share Class	139.70M
Shares Outstanding	139.78M
Shares Change (YoY)	+22.67%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	79.97%
Float	102.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	36.60
P/TBV Ratio	44.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.39.

Current Ratio	4.19
Quick Ratio	4.07
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-954.34

Financial Efficiency

Return on equity (ROE) is -107.55% and return on invested capital (ROIC) is -61.70%.

Return on Equity (ROE)	-107.55%
Return on Assets (ROA)	-53.15%
Return on Invested Capital (ROIC)	-61.70%
Return on Capital Employed (ROCE)	-138.48%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	205
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.01% in the last 52 weeks. The beta is 0.30, so COGT's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+23.01%
50-Day Moving Average	13.71
200-Day Moving Average	9.11
Relative Strength Index (RSI)	52.34
Average Volume (20 Days)	2,312,252

Short Selling Information

The latest short interest is 16.28 million, so 11.64% of the outstanding shares have been sold short.

Short Interest	16.28M
Short Previous Month	17.01M
Short % of Shares Out	11.64%
Short % of Float	15.84%
Short Ratio (days to cover)	8.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-299.66M
Pretax Income	-284.08M
Net Income	-284.08M
EBITDA	-297.12M
EBIT	-299.66M
Earnings Per Share (EPS)	-$2.52

Balance Sheet

The company has $237.85 million in cash and $60.66 million in debt, giving a net cash position of $177.19 million or $1.27 per share.

Cash & Cash Equivalents	237.85M
Total Debt	60.66M
Net Cash	177.19M
Net Cash Per Share	$1.27
Equity (Book Value)	155.04M
Book Value Per Share	0.41
Working Capital	186.59M

Cash Flow

In the last 12 months, operating cash flow was -$233.61 million and capital expenditures -$1.03 million, giving a free cash flow of -$234.65 million.

Operating Cash Flow	-233.61M
Capital Expenditures	-1.03M
Free Cash Flow	-234.65M
FCF Per Share	-$1.68

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

COGT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.67%
Shareholder Yield	-22.67%
Earnings Yield	-13.43%
FCF Yield	-11.10%

Analyst Forecast

The average price target for COGT is $22.00, which is 45.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	45.41%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.

Last Split Date	Nov 9, 2020
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1